NO20026067D0 - Systemer og fremgangsmåter for behandling av en slimoverflate - Google Patents

Systemer og fremgangsmåter for behandling av en slimoverflate

Info

Publication number: NO20026067D0
Authority: NO; Norway
Prior art keywords: treating; systems; methods; mucus surface; mucus
Prior art date: 2000-06-22

Application number

NO20026067A

Other languages

English (en)

Other versions

NO20026067L (no

Inventor

Michael J Jozwiakowski

Mark Martinez

Kenneth Phares

Jr Kenneth F Trofatter

John C Hedenstrom

Original Assignee

3M Innovative Properties Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-22

Filing date

2002-12-17

Publication date

2002-12-17

2000-09-29 Priority claimed from US09/676,339 external-priority patent/US6486168B1/en

2002-12-17 Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co

2002-12-17 Publication of NO20026067D0 publication Critical patent/NO20026067D0/no

2003-02-17 Publication of NO20026067L publication Critical patent/NO20026067L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Oncology (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Gynecology & Obstetrics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Gastroenterology & Hepatology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20026067A 2000-06-22 2002-12-17 Systemer og fremgangsmåter for behandling av en slimhinneoverflate NO20026067L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US21342000P	2000-06-22	2000-06-22
US09/676,339 US6486168B1 (en)	1999-01-08	2000-09-29	Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
PCT/US2001/019979 WO2001097795A2 (en)	2000-06-22	2001-06-22	Systems and methods for treating a mucosal surface

Publications (2)

Publication Number	Publication Date
NO20026067D0 true NO20026067D0 (no)	2002-12-17
NO20026067L NO20026067L (no)	2003-02-17

Family

ID=26908067

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20026067A NO20026067L (no)	2000-06-22	2002-12-17	Systemer og fremgangsmåter for behandling av en slimhinneoverflate

Country Status (17)

Country	Link
EP (1)	EP1296644A2 (no)
JP (1)	JP2004508851A (no)
CN (1)	CN1273110C (no)
AU (1)	AU2001270081A1 (no)
BR (1)	BR0112386A (no)
CA (1)	CA2410208A1 (no)
CZ (1)	CZ20024175A3 (no)
EE (1)	EE200200705A (no)
HR (1)	HRP20021024A2 (no)
HU (1)	HUP0301233A2 (no)
IL (1)	IL153087A0 (no)
MX (1)	MXPA02012524A (no)
NO (1)	NO20026067L (no)
NZ (1)	NZ523073A (no)
PL (1)	PL361975A1 (no)
SK (1)	SK17812002A3 (no)
WO (1)	WO2001097795A2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0211649D0 (en)	2002-05-21	2002-07-03	Novartis Ag	Organic compounds
JP2006503914A (ja)	2002-10-21	2006-02-02	エムジーアイファーマバイオロジックスインコーポレイテッド	ヒトパピローマウイルス媒介性疾患を治療するための組成物および方法
WO2005041847A2 (en) *	2003-10-22	2005-05-12	University Hospitals Of Cleveland	Method and apparatus for applying medication to internal tissue
CA2597092A1 (en)	2005-02-04	2006-08-10	Coley Pharmaceutical Group, Inc.	Aqueous gel formulations containing immune reponse modifiers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5939090A (en) *	1996-12-03	1999-08-17	3M Innovative Properties Company	Gel formulations for topical drug delivery
EP1140091B1 (en) *	1999-01-08	2005-09-21	3M Innovative Properties Company	Formulations comprising imiquimod or other immune response modifiers for treating cervical dysplasia

2001
- 2001-06-22 EP EP01948622A patent/EP1296644A2/en not_active Withdrawn
- 2001-06-22 JP JP2002503272A patent/JP2004508851A/ja not_active Abandoned
- 2001-06-22 HU HU0301233A patent/HUP0301233A2/hu unknown
- 2001-06-22 PL PL36197501A patent/PL361975A1/xx not_active Application Discontinuation
- 2001-06-22 EE EEP200200705A patent/EE200200705A/xx unknown
- 2001-06-22 CZ CZ20024175A patent/CZ20024175A3/cs unknown
- 2001-06-22 SK SK1781-2002A patent/SK17812002A3/sk not_active Application Discontinuation
- 2001-06-22 WO PCT/US2001/019979 patent/WO2001097795A2/en not_active Ceased
- 2001-06-22 AU AU2001270081A patent/AU2001270081A1/en not_active Abandoned
- 2001-06-22 IL IL15308701A patent/IL153087A0/xx unknown
- 2001-06-22 NZ NZ523073A patent/NZ523073A/xx unknown
- 2001-06-22 MX MXPA02012524A patent/MXPA02012524A/es active IP Right Grant
- 2001-06-22 BR BR0112386-6A patent/BR0112386A/pt not_active Application Discontinuation
- 2001-06-22 CN CNB018115144A patent/CN1273110C/zh not_active Expired - Fee Related
- 2001-06-22 CA CA002410208A patent/CA2410208A1/en not_active Abandoned
- 2001-06-22 HR HR20021024A patent/HRP20021024A2/hr not_active Application Discontinuation
2002
- 2002-12-17 NO NO20026067A patent/NO20026067L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2410208A1 (en)	2001-12-27
EE200200705A (et)	2004-08-16
EP1296644A2 (en)	2003-04-02
MXPA02012524A (es)	2003-04-10
WO2001097795A2 (en)	2001-12-27
NO20026067L (no)	2003-02-17
PL361975A1 (en)	2004-10-18
SK17812002A3 (sk)	2003-05-02
HRP20021024A2 (en)	2005-02-28
IL153087A0 (en)	2003-06-24
CN1273110C (zh)	2006-09-06
JP2004508851A (ja)	2004-03-25
NZ523073A (en)	2005-04-29
WO2001097795A3 (en)	2002-04-04
AU2001270081A1 (en)	2002-01-02
BR0112386A (pt)	2003-06-10
HUP0301233A2 (hu)	2003-08-28
CN1437463A (zh)	2003-08-20
CZ20024175A3 (cs)	2003-06-18

Publication	Publication Date	Title
NO20001446L (no)	2001-09-21	Fremgangsmåter og anordninger ved undersjöisk produksjonsanlegg
NO20011964L (no)	2002-02-26	Brönnbehandlingsfluider og fremgangsmåter for anvendelse derav
NO20015492D0 (no)	2001-11-09	Fremgangsmåte og anordning for flersidig forbindelse
GB2368082B8 (en)	2012-12-19	Expandable tubing and method
NO20025416D0 (no)	2002-11-12	System og fremgangsmÕte ved ekspanderbar komplettering
FI20000268L (fi)	2001-08-10	Paikannusjärjestelmä ja -menetelmä
NO20022188L (no)	2002-07-04	Flerlagssikt og fremgangsmåte for nedihulls ferdigstilling
DE60126235D1 (de)	2007-03-15	Belichtungsverfahren und -system
DK1315881T3 (da)	2009-02-02	Metode og system til perforering
NO20025507D0 (no)	2002-11-15	Brönnreferanseapparat samt fremgangsmÕte
NO20005318D0 (no)	2000-10-20	FremgangsmÕter og anordninger ved behandling av vann
DK1322597T3 (da)	2012-07-02	Fremgangsmåde og intermediære
NO20002584D0 (no)	2000-05-19	Brønnreferanseapparat og fremgangsmÕte
DE60132528D1 (de)	2008-03-13	Microlötverfahren und -vorrichtung
ATA2762000A (de)	2001-09-15	Verfahren sowie einrichtung zum wecken
EP1258299A4 (en)	2006-03-15	METHOD AND DEVICE FOR BENDING
DE60134222D1 (de)	2008-07-10	Biegeverfahren und Biegevorrichtung
NO20026067D0 (no)	2002-12-17	Systemer og fremgangsmåter for behandling av en slimoverflate
FI20001209A7 (fi)	2001-11-20	Tiedonsiirtomenetelmä ja -järjestely
AU2000239097A8 (en)	2008-05-08	Manufacturing apparatus and method
FI20002798L (fi)	2002-06-21	Menetelmä ja laitteisto putkien valmistamiseksi
NO20023959D0 (no)	2002-08-20	Flateelement og fremgangsmåte for fremstilling av et flateelement
DK1317478T3 (da)	2007-05-07	Skelnen mellem GnRH-I og GnRH-II
EP1358951A4 (en)	2006-03-15	BENDING DEVICE AND BENDING PROCESS
NO20022872D0 (no)	2002-06-14	Spröytesystem og fremgangsmåte

Legal Events

Date	Code	Title	Description
2009-03-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application